Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis
Vineet Kumar, Amit Sharma, Deepak Kumar Upadhyay, et al.
Current Drug Research Reviews (2021) Vol. 14, Iss. 1, pp. 24-36
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Small molecule drug discovery targeting the JAK-STAT pathway
You Lv, Pengbing Mi, Jeffrey J. Babon, et al.
Pharmacological Research (2024) Vol. 204, pp. 107217-107217
Open Access | Times Cited: 13
Etiopathogenesis of Psoriasis: Integration of Proposed Theories
Brenda Fernanda Hernandez-Nicols, Juan José Robledo-Pulido, Anabell Alvarado‐Navarro
Immunological Investigations (2024) Vol. 53, Iss. 3, pp. 348-415
Closed Access | Times Cited: 9
Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice
Hiroyo Shinno-Hashimoto, Akifumi Eguchi, Akemi Sakamoto, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Cutaneous Calcium/Calmodulin‐Dependent Protein Kinase II‐γ–Positive Sympathetic Nerves Secreting Norepinephrine Dictate Psoriasis
Yafen Yu, Weiwei Chen, Bao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 23
Open Access | Times Cited: 4
Enhanced antitumor efficacy of bispecific antibody blocking PD-L1 and LAG-3 with doxorubicin: mechanism and safety evaluation
Chenxing Zhang, Jiaxin Liu, Tiejun Gu, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
Risk of HBV reactivation in psoriasis vulgaris patients receiving biological agent therapy
Ayşegül Tel Kankılıç, Ömer Karakoyun, Erhan Ayhan
Cutaneous and Ocular Toxicology (2025), pp. 1-5
Closed Access
Chinese herbal medicine (Guben Qushi Huayu formula) combined with Ixekizumab in reducing psoriasis vulgaris relapse: Protocol for a mixed-methods research study
Ziqing Li, Kun‐Liang Guan, Hao Deng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Sakuranetin modulates IL-17A-related inflammation and enhances skin barrier function in an imiquimod-induced psoriasis model
Yung-Chuan Chen, Yu-Ping Cheng, Chih‐Yi Liu, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118035-118035
Closed Access
Advances in genetic–immunological targeted therapies for psoriasis
Zhen Qi, Yirui Wang, Zhuo Li, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102559-102559
Closed Access
Integrating network pharmacology and experimental validation to advance psoriasis treatment: Multi-target mechanistic elucidation of medicinal herbs and natural compounds
Hee-Geun Jo, Jihye Seo, Boyun Jang, et al.
Autoimmunity Reviews (2025), pp. 103836-103836
Closed Access
PDE4 inhibitors in psoriasis therapy: current insights and future directions
Amit Sharma, Niyati Pandoh, Keerti Dayal, et al.
Inflammopharmacology (2025)
Closed Access
Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use
Raquel Santos-Juanes Galache, Sebastián Reyes‐García, Jimena Carrero Martín, et al.
Life (2025) Vol. 15, Iss. 5, pp. 789-789
Open Access
A combination of linalool and linalyl acetate synergistically alleviates imiquimod-induced psoriasis-like skin inflammation in BALB/c mice
Vineet Kumar, Debabrata Chanda, Chandan Singh Chanotiya, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Benvitimod inhibits MCM6-meditated proliferation of keratinocytes by regulating the JAK/STAT3 pathway
Zhenguo Cai, Yibin Zeng, Xunlong Shi, et al.
Journal of Dermatological Science (2023) Vol. 109, Iss. 2, pp. 71-79
Closed Access | Times Cited: 8
Development and Pharmaceutical Evaluation of Azelaic Acid and Vitamin E Oil-Based Nanoemulgel of Tacrolimus for Topical Application in Plaque Psoriasis
Vineet Kumar, Ankita Roy, Alok Sharma, et al.
Journal of Pharmaceutical Innovation (2023) Vol. 18, Iss. 4, pp. 1616-1625
Closed Access | Times Cited: 8
Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis
Jieyi Wang, Jing Gao, Cong Huang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 12
Keratinocyte exosomal LOC285194 ameliorates psoriasis by inhibiting the differentiation of CD4+T cells to Th17 cells through regulating miR‐211‐5p/SIRT1 axis
Jin Lin, Yi Cao, Lili Ma, et al.
IUBMB Life (2024) Vol. 77, Iss. 1
Closed Access | Times Cited: 2
Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody that targets interleukin-17A, in healthy participants and patients with moderate-to-severe plaque psoriasis
Congjun Jiang, Yu Du, X J Liu, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 1, pp. 28-36
Closed Access | Times Cited: 6
Site-Specifically Launched Microneedles for the Combined Treatment of Psoriasis-Diabetic Comorbidity
Xinyi Gao, Fapeng Zhang, Yao Huang, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 40, pp. 46613-46625
Closed Access | Times Cited: 6
Inflammatory and Immunomodulatory Effects of Tripterygium wilfordii Multiglycoside in Mouse Models of Psoriasis Keratinocytes
Shuo Zhang, Hongjin Li, Chun-mei Yang, et al.
Chinese Journal of Integrative Medicine (2023) Vol. 30, Iss. 3, pp. 222-229
Closed Access | Times Cited: 4
Therapeutic Effect of Lecigel, Cetiol®CC, Activonol-6, Activonol-M, 1,3-Propanediol, Soline, and Fucocert® (LCAA-PSF) Treatment on Imiquimod-Induced Psoriasis-like Skin in Mice
Chih-Ching Li, Chih‐Chien Lin, Chun‐Yi Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7720-7720
Open Access | Times Cited: 1
Is Mir-205 a possible biomarker for evaluating treatment response in psoriasis?
Carina Mihu, Codruța Alina Popescu, Diana Cenariu, et al.
Journal of Medicine and Life (2024) Vol. 17, Iss. 3, pp. 353-359
Open Access | Times Cited: 1
Assessment of mechanisms of infectious pneumonia based on expression of fibrinogen, procalcitonin, high-sensitivity C-reactive protein expression, T helper 17 cells, regulatory T cells interleukin-10, and interleukin-17
Dao‐Ming Zu, Lei Zhang
Translational Pediatrics (2022) Vol. 11, Iss. 1, pp. 73-84
Open Access | Times Cited: 6
LY294002 ameliorates psoriatic skin inflammation in mice via blocking the Notch1/Hes1-PTEN/AKT/IL-17A feedback loop
Yawen Lin, Xiaofeng Zhu, Yiwen Li, et al.
Clinical & Experimental Immunology (2023) Vol. 213, Iss. 1, pp. 114-124
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top